Advocate for biotech/biopharma research & development as Sr Counsel/Executive Director-CT Bioscience Growth Council, Chair-WeWorkForHealthCT
Hartford, CT
Joined November 2014
- Tweets945
- Following323
- Followers276
- Likes504
Paul Pescatello retweeted
“We’ve got to tell the story about a difference that we’re making in people’s lives,” @GovNedLamont said during a visit to CBIA member @ViiVUS honoring the company’s growth and breakthroughs in HIV treatment. ctinsider.com/business/artic…
#research #innovation #Connecticut
Paul Pescatello retweeted
Well-deserved recognition for Branford-based @ViiVUS, honored by @GovNedLamont for its global efforts to end HIV/AIDS. ViiV's cutting-edge research is at the forefront in the battle to end HIV, helping create 17 medications used by thousands of people across the globe.
Paul Pescatello retweeted
“#Innovation isn’t just technology, robots, and hardware,” @ChrisDipentima tells @WTNH's @MikeCerulliCT and @thevoiceofct's Melissa Sheketoff on MADE Conversations about how businesses innovate in areas like employee #engagement and #workplace culture. bit.ly/4mIPJqI
Paul Pescatello retweeted
The @US_FDA accepted @novonordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the drug in the fourth quarter of this year.
#FDA #GLP1 #wegovy #biospace
hubs.li/Q03l1wT70
Paul Pescatello retweeted
🎙️Out now! The bonus episodes of Science Will Win Season 4 recorded at SXSW are live! Hear how digital tools are empowering patients & how teamwork is key in the fight to out do cancer. Tune in on your favorite podcast app! 🎧 on.pfizer.com/42g1QmR
Paul Pescatello retweeted
#NEWS:Arvinas Presents First-in-Human Data for Investigational Oral novel PROTAC LRRK2 Degrader Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation.
Read More: bit.ly/4hXSctC
Paul Pescatello retweeted
AstraZeneca’s Imfinzi regimen approved by FDA to treat bladder cancer dlvr.it/TJtJPq #News #Regulatory #AstraZeneca
Paul Pescatello retweeted
“We’ve really hit our stride over the last couple of years in terms of new companies being born out of academic labs, and otherwise getting funding and starting in Connecticut,” CBIA's @CTBio tells @HartfordBiz about #Connecticut’s #bioscience industry.
hartfordbusiness.com/article…
Paul Pescatello retweeted
CBIA Bioscience Growth Council’s @CTBio joined patients, advocates, policymakers, and industry leaders to highlight #RareDiseaseDay2025—raising awareness about these life-changing conditions and the #research and #innovation underway to improve the lives of patients and families.
Paul Pescatello retweeted
GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval dlvr.it/TJ1njL #News #Regulatory #FDA
Paul Pescatello retweeted
Early bird registration for the Yale Innovation Summit is now open! Secure your discounted tickets for the region’s largest gathering of entrepreneurs, investors, and industry on May 28-29, 2025. Register & learn more: bit.ly/YISEarly2025 #YaleInnovation25
Paul Pescatello retweeted
CBIA’s 2025 Healthcare Summit brought together industry leaders for important conversations with practical strategies for employers on managing rising #healthcare costs, finding the right #benefits plans, and maximizing employee #engagement.
Paul Pescatello retweeted
Boehringer’s nerandomilast shows promise in phase 3 pulmonary fibrosis study dlvr.it/THx5t0 #Research #News #BoehringerIngelheim
Paul Pescatello retweeted
The biophama industry is at a critical turning point. @CTBio highlights how the industry is innovating to improve healthcare with @pfizer’s Adam Gilbert, BioMed X’s Mark Johnston, and @ViivUS’s Samir Joshi. #healthcare #Connecticut
Paul Pescatello retweeted
New research in @NatureComms shows how our ePsCas9 gene editing system offers greater precision. This specificity represents an important advancement in #GenomicMedicine with potential for many rare diseases. Learn more: spr.ly/6015aZ7FZ
Paul Pescatello retweeted
Do you know a middle schooler who is passionate about civics and engaged in their community? Encourage them to enter the 2025 #NationalCivicsBee! Applications are being accepted now through Feb. 4!
Learn more: cbia.com/news/issues-policie…
Paul Pescatello retweeted
Looking to keep the momentum going after #JPMWeek25? #BIOCEO25 is the perfect place to spark new partnerships and follow up on your conversations.
Learn More: bcic.bio.org/bio-partnering
Paul Pescatello retweeted
Sanofi and Alloy Therapeutics enter central nervous system deal worth over $427m dlvr.it/THG5TZ #News #Sales #AlloyTherapeutics
Paul Pescatello retweeted
#NEWS: Arvinas and @Pfizer Announce Preliminary Phase 1b Data for an Investigational Treatment Combination in Locally Advanced or Metastatic Hormone Receptor-Positive, Human Growth Hormone Receptor 2-Negative (ER+/HER2-) Breast Cancer. Read the release here: bit.ly/49w2SNu
Paul Pescatello retweeted
“What we really need are those policies coming out of Hartford that encourage that growth, that provide access to affordable #childcare, that provide access to affordable #healthcare,” Chris Davis tells @talkofct about solving the state’s #employment challenges. #reimagineCT